Long-term treatment with the second-generation nucleoside analogue lamivudine (lam) efficiently inhibits HBV replication with frequent viral polymerase mutations.

• 二代拉米夫定的长期应用可以有效地抑制病毒多聚酶突变频繁的HBV发生复制。